MD NewslineHigh-Intensity Statins Lower Recurrent Events After Coronary Intervention

ℹ️ Observational Association Only Evidence

This retrospective cohort examined statin intensity and LDL-C in 45,949 adults with coronary artery disease after PCI or CABG. High-intensity therapy was associated with fewer recurrent events and deaths than no statin over a median six years. Associations persisted across LDL-C categories. Unlike the edition’s plaque-imaging trial, this analysis assessed clinical outcomes, but nonrandomized treatment selection limits causal interpretation. The very-low-LDL-C findings cannot establish a treatment threshold.

Clinical Considerations

• 65% received high-intensity statins, 25% lower-intensity therapy, and 10% no statin; the report does not establish reasons for treatment differences.
• MI incidence was 21.6 versus 65.3 per 1,000 person-years with high-intensity therapy versus no statin; these are reported incidence rates.
• Mortality rates were 27.9 versus 71.3 per 1,000 person-years; lower-intensity therapy also showed lower mortality than no statin.
• Adjusted MI hazard ratios favored high-intensity therapy across LDL-C strata, but the highlighted comparator was no statin, not lower-intensity treatment.
• LDL-C below 55 mg/dL was associated with higher MI and mortality than 55–70 mg/dL; this does not establish harm from lowering LDL-C.
• Exposure misclassification, treatment changes, nonadjudicated events, residual confounding, and survivorship bias limit interpretation; prescriptions do not establish adherence.

Practice Applications

• Review prescribed intensity, tolerability, and adherence during post-revascularization follow-up rather than assuming a recorded prescription reflects sustained treatment.
• Interpret the very-low-LDL-C subgroup cautiously; this analysis alone does not justify deintensifying therapy or revising LDL-C targets.
• Recognize the distinction between real-world outcome associations and randomized evidence when discussing treatment benefits with patients.